세계의 치료용 아페레시스 시장 : 기술별, 처치 유형별, 최종 사용자별, 용도별, 컴포넌트별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2025-2032년)

The Therapeutic Apheresis Market size was valued at US$ 2,879.23 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.

Therapeutic apheresis is a medical procedure that involves drawing blood from a patient, processing it to remove specific components, and then returning it to the body. The Therapeutic Apheresis market is primarily driven by the growing global burden of autoimmune and neurological disorders, which is increasing clinical demand for plasma exchange and other procedures. The growing use of apheresis in advanced cell therapies, particularly CAR-T and stem-cell treatments, presents a significant opportunity for device manufacturers and service providers to generate new revenue streams. However, market growth is constrained by the high cost of equipment and procedures, preventing widespread adoption in low- and middle-income countries. The market is being shaped by a rapid shift toward automated, AI-enabled apheresis systems designed to improve patient outcomes, reduce procedure time, and increase safety.

Therapeutic Apheresis Market- Market Dynamics

Rise In Chronic Conditions Is Anticipated To Fuel The Market Growth

The rise in chronic conditions is expected to drive the apheresis consumables and equipment market forward. Chronic conditions, also known as chronic diseases, are long-term health conditions that persist for an extended period of time, often for the rest of a person's life, and are typically incurable. Apheresis consumables and equipment are critical for managing chronic diseases because they allow for the targeted removal or collection of blood components in conditions such as autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvest. For instance, the National Library of Medicine, a government medical library based in the United States, predicts that by 2035, nearly 36% of US adults aged 50 and older will have at least one chronic condition, with that figure expected to rise to nearly 48% by 2050. As a result, the rise in chronic conditions is propelling the apheresis consumables and equipment market.

Therapeutic Apheresis Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Technology, Procedure Type, End User, Application, Component, and Region.

The component segmentation, which comprises five major groups, Plasmapheresis, LDL Apheresis, Leukapheresis, Photopheresis, and Others. Among this, plasmapheresis accounted for a significant share of the Global Apheresis Market. Its strong position is supported by the rising prevalence of autoimmune and neurological disorders, driven by genetic predispositions and shifting lifestyle patterns. According to the Multiple Sclerosis International Federation, the number of people living with Multiple Sclerosis increased from 2.8 million in 2020 to 2.9 million in 2023, highlighting the expanding population requiring therapeutic interventions. Plasmapheresis plays a vital role in managing such conditions by removing inflammatory agents, autoantibodies, and other damaging substances from the bloodstream, leading to reduced severity and duration of disease relapses. As a result, healthcare professionals are increasingly recommending this procedure as part of treatment strategies, contributing to the continued growth of the plasmapheresis segment.

Based on End-User segment, Blood banks are one of the most visible and highly utilized segments in the Therapeutic Apheresis Market, owing to their critical role in collecting, processing, and supplying blood components required for therapeutic and emergency medical purposes. These facilities routinely perform apheresis procedures, such as plasmapheresis, plateletpheresis, and leukapheresis, to ensure the availability of specialized blood components for patients suffering from autoimmune, oncological, and hematological diseases. Their established infrastructure, standardized operating protocols, and high donor throughput allow them to meet the steady demand for advanced apheresis systems and consumables. The segment's importance is bolstered by ongoing efforts to increase donor engagement and strengthen blood collection capacity. For instance, in 2023, a new blood collection center was opened at Singapore's One Punggol integrated community hub to meet rising demand and encourage increased donor participation, particularly among young people. Such developments highlight the growing emphasis on establishing strong blood-collection networks, emphasizing why blood banks remain an important and rapidly expanding component of the therapeutic apheresis landscape.

Therapeutic Apheresis Market- Geographical Insights

North America holds a prominent market share in the global apheresis market. Chronic diseases are common in North American countries, and there is a large patient population suffering from hematological diseases. For instance, the Global Cancer Observatory estimates that approximately 71.7 thousand new cases of leukemia will be reported in North America in 2022. Similarly, the Centers for Disease Control and Prevention (CDC) reported in 2023 that sickle cell disease (SCD) affects approximately 100,000 Americans. This necessitates the need for the best therapeutic solutions, which drives the North American Apheresis Market. Furthermore, the per capita consumption in these countries is increasing, resulting in significant growth in health expenditure. Individuals are increasingly opting for advanced therapies as economic growth accelerates, boosting market growth.

United States Therapeutic Apheresis Market- Country Insights

The United States is the region's major market. The increasing geriatric population in the United States is driving market growth. As the population ages, more cancer cases and chronic diseases are likely to emerge. This factor will help to drive regional market growth. The growing burden of blood-related ailments such as kidney disease, metabolic diseases, cancer, and neurological disorders, the presence of established healthcare infrastructure, and high patient awareness levels are the primary factors driving the growth of the studied market in North America. According to the Leukemia & Lymphoma Society (LLS), someone in the United States is diagnosed with blood cancer every three minutes. Approximately 178,520 people in the United States were diagnosed with leukemia, lymphoma, or myeloma in 2020. Leukemia, lymphoma, and myeloma accounted for 9.8% of the 1,898,160 new cancer cases diagnosed in the United States in 2021. As a result, the high incidence of target diseases drives the market's growth.

Therapeutic Apheresis Market- Competitive Landscape:

The therapeutic apheresis market has a moderately consolidated competitive environment, with innovation, technology integration, and procedural efficiency playing important roles in differentiation. Companies in this space compete primarily by developing advanced apheresis systems that provide increased automation, improved safety profiles, and shorter procedure times. Consumables, service contracts, and training programs are critical components of competitive strategy, as healthcare facilities increasingly prefer vendors who provide comprehensive operational support. Market participants are also focusing on expanding indications, such as autoimmune, neurological, and cell-therapy applications, to increase clinical relevance and adoption. Regulatory approvals, evidence-based clinical data, and integration with digital monitoring platforms help to define competitive advantages.

Recent Developments:

In August 2023, TERUMO BCT, INC received FDA approval for a groundbreaking platelet device that converts blood into platelets in a single centrifugation cycle, increasing the speed and reliability of blood component preparation.

In August 2023, Fresenius Kabi AG and Lupagen Inc. have signed a new supply and development agreement. This collaboration focuses on developing technologies to improve the delivery of cell and gene therapies directly to patients in clinical settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC APHERESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Baxter Healthcare Corporation
• Kawasumi Laboratories Inc.
• Therakos Incorporation
• Mallinckrodt Plc
• Asahi Kasei Medical Co.
• Haemonetics Corporation
• Miltenyi Biotec
• Terumo BCT
• Asahi Kasei Medical
• B. Braun Melsungen AG
• Nikkiso Co. Ltd.
• Cerus Corporation
• Terumo BCT Inc.
• Fresenius Kabi USA
• Medica S.p.A.
• Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Centrifugation
• Membrane filtration

GLOBAL THERAPEUTIC APHERESIS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

• Therapeutic plasma exchange (TPE)
• Cellular depletions
• Red blood cell exchange (RBCX)
• Other procedures

GLOBAL THERAPEUTIC APHERESIS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Specialty clinics
• Blood banks
• Ambulatory surgical centers

GLOBAL THERAPEUTIC APHERESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Neurology
• Oncology
• Sickle cell disease
• Autoimmune disease
• Graft-versus-host disease (GVHD)
• Nephrology
• Familial hypercholesterolemia
• Transplant of solid organs

GLOBAL THERAPEUTIC APHERESIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

• Plasmapheresis
• LDL Apheresis
• Leukapheresis
• Photopheresis
• Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Therapeutic Apheresis Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Therapeutic Apheresis Market Snippet by Technology
  • 2.1.2. Therapeutic Apheresis Market Snippet by Procedure Type
  • 2.1.3. Therapeutic Apheresis Market Snippet by End User
  • 2.1.4. Therapeutic Apheresis Market Snippet by Application
  • 2.1.5. Therapeutic Apheresis Market Snippet by Component
  • 2.1.6. Therapeutic Apheresis Market Snippet by Country
  • 2.1.7. Therapeutic Apheresis Market Snippet by Region
• 2.2. Competitive Insights

3. Therapeutic Apheresis Key Market Trends

• 3.1. Therapeutic Apheresis Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Therapeutic Apheresis Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Therapeutic Apheresis Market Opportunities
• 3.4. Therapeutic Apheresis Market Future Trends

4. Therapeutic Apheresis Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Therapeutic Apheresis Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Therapeutic Apheresis Market Landscape

• 6.1. Therapeutic Apheresis Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Therapeutic Apheresis Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
  • 7.1.2. Centrifugation
  • 7.1.3. Membrane filtration

8. Therapeutic Apheresis Market - By Procedure Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
  • 8.1.2. Therapeutic plasma exchange (TPE)
  • 8.1.3. Cellular depletions
  • 8.1.4. Red blood cell exchange (RBCX)
  • 8.1.5. Other procedures

9. Therapeutic Apheresis Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Specialty clinics
  • 9.1.4. Blood banks
  • 9.1.5. Ambulatory surgical centers

10. Therapeutic Apheresis Market - By Application

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
  • 10.1.2. Neurology
  • 10.1.3. Oncology
  • 10.1.4. Sickle cell disease
  • 10.1.5. Autoimmune disease
  • 10.1.6. Graft-versus-host disease (GVHD)
  • 10.1.7. Nephrology
  • 10.1.8. Familial hypercholesterolemia
  • 10.1.9. Transplant of solid organs

11. Therapeutic Apheresis Market - By Component

• 11.1. Overview
  • 11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
  • 11.1.2. Plasmapheresis
  • 11.1.3. LDL Apheresis
  • 11.1.4. Leukapheresis
  • 11.1.5. Photopheresis
  • 11.1.6. Others

12. Therapeutic Apheresis Market- By Geography

• 12.1. Introduction
  • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 12.2. North America
  • 12.2.1. Overview
  • 12.2.2. Therapeutic Apheresis Key Manufacturers in North America
  • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.2.5. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.2.9. U.S.
    • 12.2.9.1. Overview
    • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.9.4. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.2.10. Canada
    • 12.2.10.1. Overview
    • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.10.4. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
• 12.3. Europe
  • 12.3.1. Overview
  • 12.3.2. Therapeutic Apheresis Key Manufacturers in Europe
  • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.3.5. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.9. Germany
    • 12.3.9.1. Overview
    • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.9.4. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.10. UK
    • 12.3.10.1. Overview
    • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.10.4. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.11. France
    • 12.3.11.1. Overview
    • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.11.4. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.12. Italy
    • 12.3.12.1. Overview
    • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.12.4. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.13. Spain
    • 12.3.13.1. Overview
    • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.13.4. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.14. The Netherlands
    • 12.3.14.1. Overview
    • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.14.4. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.15. Sweden
    • 12.3.15.1. Overview
    • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.15.4. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.16. Russia
    • 12.3.16.1. Overview
    • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.16.4. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.17. Poland
    • 12.3.17.1. Overview
    • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.17.4. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3.18. Rest of Europe
    • 12.3.18.1. Overview
    • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
• 12.4. Asia Pacific (APAC)
  • 12.4.1. Overview
  • 12.4.2. Therapeutic Apheresis Key Manufacturers in Asia Pacific
  • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.4.5. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.9. China
    • 12.4.9.1. Overview
    • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.9.4. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.10. India
    • 12.4.10.1. Overview
    • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.10.4. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.11. Japan
    • 12.4.11.1. Overview
    • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.11.4. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.12. South Korea
    • 12.4.12.1. Overview
    • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.12.4. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.13. Australia
    • 12.4.13.1. Overview
    • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.13.4. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.14. Indonesia
    • 12.4.14.1. Overview
    • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.14.4. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.15. Thailand
    • 12.4.15.1. Overview
    • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.15.4. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.16. Philippines
    • 12.4.16.1. Overview
    • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.16.4. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4.17. Rest of APAC
    • 12.4.17.1. Overview
    • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.17.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
• 12.5. Latin America (LATAM)
  • 12.5.1. Overview
  • 12.5.2. Therapeutic Apheresis Key Manufacturers in Latin America
  • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.5.5. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5.9. Brazil
    • 12.5.9.1. Overview
    • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.9.4. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5.10. Mexico
    • 12.5.10.1. Overview
    • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.10.4. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5.11. Argentina
    • 12.5.11.1. Overview
    • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.11.4. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5.12. Colombia
    • 12.5.12.1. Overview
    • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.12.4. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5.13. Rest of LATAM
    • 12.5.13.1. Overview
    • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
• 12.6. Middle East and Africa
  • 12.6.1. Overview
  • 12.6.2. Therapeutic Apheresis Key Manufacturers in Middle East and Africa
  • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.6.5. Middle East and Africa Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.9. Saudi Arabia
    • 12.6.9.1. Overview
    • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.10. United Arab Emirates
    • 12.6.10.1. Overview
    • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.11. Israel
    • 12.6.11.1. Overview
    • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.11.4. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.12. Turkey
    • 12.6.12.1. Overview
    • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.12.4. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.13. Algeria
    • 12.6.13.1. Overview
    • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.13.4. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.14. Egypt
    • 12.6.14.1. Overview
    • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.14.4. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6.15. Rest of MEA
    • 12.6.15.1. Overview
    • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.15.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Therapeutic Apheresis Industry

• 13.1. Competitive Benchmarking
  • 13.1.1. Competitive Dashboard
  • 13.1.2. Competitive Positioning
• 13.2. Company Profiles
  • 13.2.1. Baxter Healthcare Corporation
  • 13.2.2. Kawasumi Laboratories Inc.
  • 13.2.3. Therakos Incorporation
  • 13.2.4. Mallinckrodt Plc
  • 13.2.5. Asahi Kasei Medical Co.
  • 13.2.6. Haemonetics Corporation
  • 13.2.7. Miltenyi Biotec
  • 13.2.8. Terumo BCT
  • 13.2.9. Asahi Kasei Medical
  • 13.2.10. B. Braun Melsungen AG
  • 13.2.11. Nikkiso Co. Ltd.
  • 13.2.12. Cerus Corporation
  • 13.2.13. Terumo BCT Inc.
  • 13.2.14. Fresenius Kabi USA
  • 13.2.15. Medica S.p.A.
  • 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

• 15.1. Research Methodology
• 15.2. References
• 15.3. Abbreviations
• 15.4. Disclaimer
• 15.5. Contact Us